Want to join the conversation?
During 1Q16, $CLX reported lower free cash flow of $107MM or about 8% of sales compared to 1Q15. This decline was largely due to higher employee incentive compensation payments related to strong FY15 results. Looking forward, $CLX anticipates free cash flow for FY16 to be about 10% of sales.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.